What does this TikTok creator claim about Ozempic?
@heal_withb says taking Ozempic was "one of the WORST decisions" she's ever made and that she didn't do proper research beforehand. She also claims doctors haven't been able to help her with side effects or her underlying endometriosis.
The video doesn't specify what negative effects she experienced from semaglutide. She connects her bad experience to broader frustrations with healthcare for chronic conditions like endometriosis and PCOS.
Are serious Ozempic side effects actually documented?
Yes, clinical trials show semaglutide can cause significant side effects that persist even after stopping the medication. The STEP 1 trial (Wilding et al., NEJM, 2021) found 74% of participants experienced gastrointestinal side effects including nausea, diarrhea, and vomiting.
More concerning are emerging reports of gastroparesis (stomach paralysis) that can last months after discontinuation. A 2023 study in JAMA found increased risk of gastrointestinal complications compared to other weight loss medications.
The SUSTAIN trials also documented cases of pancreatitis, gallbladder problems, and kidney issues. These aren't rare outliers but documented risks that some patients experience severely.
Does the healthcare system adequately prepare patients?
This is where the creator makes her strongest point. Many patients report being inadequately counseled about potential long-term effects before starting semaglutide.
The prescribing information lists gastroparesis and other serious side effects, but anecdotal reports suggest rushed consultations don't always cover these thoroughly. The STEP trials required extensive monitoring that often doesn't happen in real-world prescribing.
Her frustration about doctors being unable to help with persistent side effects also rings true. There's limited research on treating post-semaglutide gastroparesis or other lasting complications.
What's missing from her account?
The creator doesn't specify her indication for taking Ozempic or whether she was using it off-label for weight loss versus diabetes management. This context matters for risk-benefit analysis.
She also doesn't detail which specific side effects she experienced or their timeline. Without knowing whether she had gastroparesis, severe nausea, or other documented complications, it's hard to evaluate her experience against known data.
Her comment about not doing research beforehand suggests some personal responsibility, though this doesn't excuse inadequate medical counseling if that occurred.
What should potential users actually know?
The STEP and SUSTAIN trials show semaglutide works for weight loss and diabetes management, but side effects are common and can be severe. About 7% of STEP 1 participants discontinued due to adverse events.
If you're considering semaglutide, ask specifically about gastroparesis risk, gallbladder complications, and what happens if you need to stop suddenly. Get clear protocols for managing side effects before they occur.
The creator's experience with unhelpful follow-up care is unfortunately common. Make sure your prescribing doctor has experience managing semaglutide complications, not just prescribing it.